查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2024533

DNA定序產品市場報告：按產品類型、應用、最終用戶和地區分類（2026-2034年）

DNA Sequencing Products Market Report by Product Type, Application, End-User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球DNA定序產品市場規模達82億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到171億美元，2026年至2034年的複合年成長率（CAGR）為8.24%。推動市場成長的因素包括：人們對祖源檢測和系譜研究的興趣日益濃厚；基於雲端和人工智慧的生物資訊解決方案的興起；DNA定序在非侵入性產前檢測和癌症診斷中的應用日益廣泛；以及學術機構、醫療服務提供者和生物技術公司之間合作的不斷加強。

DNA定序產品市場趨勢：

慢性病盛行率增加

慢性病盛行率的上升是市場成長的關鍵促進因素。癌症發生率的不斷攀升推動了對DNA定序的需求。例如，根據世界衛生組織（WHO）估計，2022年全球新增癌症病例約2,000萬例，死亡人數約970萬人。此外，據美國國家癌症研究所稱，約5%至10%的癌症被認為是由遺傳自父母的有害基因突變引起的。由於這些健康問題持續影響全球大部分人口，因此對能夠進行有效治療和管理的精準早期診斷的需求日益成長，這為DNA定序產品製造商創造了盈利的市場機會。此外，分析個體的DNA能夠幫助醫療專業人員識別導致這些疾病發展的特定遺傳因素，從而根據個體獨特的基因組成製定個人化的治療方案。而且，隨著我們對疾病遺傳基礎的理解不斷加深，DNA定序對於高風險族群的早期篩檢和預測性檢測正變得至關重要。例如，根據Psomagen公司的一篇部落格文章，DNA定序將使臨床醫生能夠根據每位患者的數據，更深入地了解疾病風險以及預防/治療方案。這包括能夠識別多種疾病中的多種基因變異這一優勢。預計這些因素將進一步擴大DNA定序產品的市佔率。

DNA定序在藥物研發的應用日益廣泛

DNA定序在藥物研發領域的日益普及正在推動市場發展。 DNA定序透過提供關於疾病遺傳基礎、潛在治療標靶和個人化醫療的寶貴訊息，徹底改變了藥物發現過程。例如，根據美國國家醫學圖書館發表的報導報導，新一代定序（NGS）技術正被大規模應用於識別和表徵人類基因中潛在的功能性變異，以更深入地了解基因在疾病中的作用以及藥物療法的有效性。後者對於正在發展的個人化醫療（精準醫療）領域尤其重要。此外，DNA定序正在加速罕見疾病的研究以及先前難以闡明的新型藥物標靶的發現。這使得研究人員能夠以前所未有的細節水平了解疾病背後的分子機制，從而為精準醫療的發展鋪路。例如，佛羅裡達州立大學於2024年2月成立了兒童罕見疾病研究所，旨在促進罕見兒童疾病的研究和治療。該研究所計劃利用人工智慧和DNA定序技術，加速開發創新技術，以改善戴-薩克斯病和膠質母細胞瘤等罕見兒童疾病的診斷和治療，並提供包括基因療法在內的多種極具前景的新治療方案。這些因素將進一步推動DNA定序產品市場的收入成長。

在農業領域擴大應用

DNA定序產品在農業領域的廣泛應用正在推動市場成長。 DNADNA測序技術透過對作物、牲畜和農業害蟲進行精準高效的基因組分析，徹底改變了農業領域。在作物改良方面，DNA定序對於確保食品安全至關重要，它能夠識別與抗病性、產量潛力和營養成分等優良性狀相關的遺傳標記。例如，2023年6月，來自九個非洲國家的頂尖科學家齊聚加納首都阿克拉，發布了一系列旨在提高食品安全和控制抗菌素抗藥性（AMR）的新型診斷測試。此次會議由聯合國糧食及農業組織（糧農組織）主辦，為實驗室DNA測序技術和生物資訊學提供了指導。預計這將進一步對近期DNA定序產品的定價產生正面影響。此外，DNA定序對於研究農業害蟲和病原體也至關重要，它有助於制定有針對性的害蟲管理策略，從而減少有害化學物質的使用，促進永續農業發展。例如，2023年3月，明尼蘇達大學的學生對大豆蚜蟲（一種威脅大豆的害蟲，而大豆是世界上種植和消費最廣泛的作物之一）進行了關鍵基因測序。隨著農業部門尋求創新和高效的方式來提高生產力和永續性，對DNA定序產品的需求預計將進一步成長。這將加速農業活動的進展，有助於全球糧食安全，並最終對DNA定序產品市場的前景產生正面影響。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球DNA定序產品市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場區隔：依產品類型
  • 市場區隔：按應用領域
  • 市場區隔：依最終用戶分類
  • 市場區隔：依技術分類
  • 市場區隔：按地區
  • 市場預測
  • SWOT分析
  • 價值鏈分析
  • 波特五力分析

第6章 市場區隔：依產品類型分類

  • 耗材和試劑
  • 裝置

第7章 市場區隔：依應用領域分類

  • 生物標記
  • 診斷
  • 生殖健康
  • 法醫學
  • 個人化醫療
  • 其他

第8章 市場區隔：依最終用戶分類

  • 學術和政府附屬研究機構
  • 製藥和生物技術公司
  • 醫院和診所
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第10章 競爭格局

  • 市場結構
  • Market Breakup：by Key Players
  • 主要公司簡介
    • Illumina Inc
    • Thermo Fisher Scientific Inc.
    • F. Hoffmann-La Roche Ltd.
    • Pacific Biosciences of California, Inc.
    • Beckman Coulter
Product Code: SR112026A839

The global DNA sequencing products market size reached USD 8.2 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 17.1 Billion by 2034, exhibiting a growth rate (CAGR) of 8.24% during 2026-2034. The increasing interest in ancestry testing and genealogy, the emergence of cloud-based and AI-driven bioinformatics solutions, the rising integration of DNA sequencing into non-invasive prenatal testing and cancer diagnostics, and the growing collaborations between academic institutions, healthcare providers, and biotechnology companies are some of the factors propelling the market growth.

DNA SEQUENCING PRODUCTS MARKET ANALYSIS:

  • Major Market Drivers: The increasing prevalence of genetic diseases and the rising awareness of the importance of genetic testing for preventive healthcare are primarily driving the market growth. Moreover, rapid technological advancements coupled with the expanding applications of DNA sequencing across diverse fields are further contributing to the DNA sequencing products market share.
  • Key Market Trends: Declining cost of DNA sequencing, surging prevalence of chronic diseases, rising application in healthcare practices, enhanced focus on precision medicine, and continuous advancements in bioinformatics are expected to proliferate the DNA sequencing market growth. Moreover, collaborations and partnerships between sequencing technology providers and research institutions have accelerated product development and adoption.
  • Competitive Landscape: Some of the leading DNA sequencing products market companies are Illumina Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Pacific Biosciences of California, Inc., and Beckman Coulter, among many others.
  • Geographical Trends: According to the report, North America accounted for the largest market share. The region is a hub for innovation in NGS technologies, with numerous companies and research institutions driving advancements in sequencing platforms, reagents, and bioinformatics tools. These technological advancements, such as improvements in sequencing accuracy, throughput, and cost-effectiveness, are expanding the applications of DNA sequencing in both research and clinical settings.
  • Challenges and Opportunities: High costs associated with DNA sequencing, accuracy and reliability, standardization, and legal issues are some of the key challenges hampering the market growth. However, DNA sequencing has the potential to revolutionize healthcare by enabling personalized medicine tailored to an individual's genetic makeup. It allows for more accurate diagnosis, prognosis, and treatment selection.

DNA SEQUENCING PRODUCTS MARKET TRENDS:

Increasing Prevalence of Chronic Disorders

The increasing prevalence of chronic disorders has become a significant factor catalyzing the market. The rising incidence of cancer is driving the demand for DNA sequencing. For instance, according to the World Health Organization (WHO), in 2022, there were an estimated 20 million new cancer cases and around 9.7 million deaths. Also, according to the National Cancer Institute, nearly 5%-10% of all cancers are thought to be caused by harmful genetic changes that are inherited from a parent. As these health conditions continue to affect a large portion of the global population, there is a growing need for accurate and early diagnosis to facilitate effective treatment and management, thereby providing lucrative DNA sequencing product's market opportunities for the manufacturers. Moreover, by analyzing an individual's DNA, healthcare professionals can pinpoint specific genetic factors contributing to the development of these conditions, enabling personalized treatment plans based on a person's unique genetic makeup. Furthermore, as the understanding of the genetic basis of diseases advances, DNA sequencing becomes essential in early screening and predictive testing for individuals at risk. For instance, according to the blog published by Psomagen, DNA sequencing enables clinicians to have a better understanding of illness risk, as well as prevention and therapy options, depending on the data from each patient. This includes the advantage of becoming acquainted with multiple genetic variants in various diseases. These factors are further expected to add to the DNA sequencing products market share.

Rising Adoption of DNA Sequencing in Pharmaceutical Research and Drug Development

The rising adoption of DNA sequencing in pharmaceutical research and drug development is propelling the market. DNA sequencing has revolutionized the drug discovery process by providing invaluable insights into the genetic basis of diseases, potential therapeutic targets, and personalized medicine. For instance, according to the article published by the National Library of Medicine, large-scale applications of NGS techniques have been made to identify and characterize potentially functional variation in human genes in order to better understand the role that genetics plays in disease and the effects of drug treatments, the latter of which is particularly relevant to the developing field of personalized or precision medicine. Apart from this, DNA sequencing facilitates the study of rare diseases and the discovery of novel drug targets that were previously elusive. It allows researchers to understand the underlying molecular mechanisms of diseases at a level of detail never before possible, paving the way for the development of precision medicines. For instance, in February 2024, Florida State University established the Institute for Pediatric Rare Diseases, dedicated to promoting research and providing treatments for uncommon kids' diseases. The institute will accelerate the development of revolutionary technologies to better diagnose and cure rare diseases in children, such as Tay-Sachs and glioblastoma, by leveraging artificial intelligence and DNA sequencing to provide promising new treatment options such as gene therapy. These factors are further bolstering the DNA sequencing products market revenue.

Growing Usage in the Agriculture Sector

The growing use of DNA sequencing products in agricultural practices has driven the market growth. DNA sequencing technologies have revolutionized the agricultural industry by enabling precise and efficient genomic analysis of crops, livestock, and agricultural pests. In crop improvement, DNA sequencing is crucial in identifying genetic markers associated with desirable traits such as disease resistance, yield potential, and nutritional content to ensure food safety. For instance, in June 2023, proficient scientists from nine African nations gathered in Accra, Ghana, to initiate a fresh round of diagnostic examinations targeted at enhancing food safety and managing antimicrobial resistance (AMR). The Food and Agriculture Organization of the United Nations (FAO) facilitated the meeting, which featured instruction on DNA sequencing techniques in the lab and bioinformatics. This is further expected to positively influence the DNA sequencing products market's recent price. Furthermore, DNA sequencing is instrumental in studying agricultural pests and pathogens, enabling the development of targeted pest management strategies that reduce the use of harmful chemicals and promote sustainable agriculture. For instance, in March 2023, students at the University of Minnesota performed critical genome sequencing for the soybean gall midge, a pest that threatened the soybean crop, which was one of the most frequently farmed and consumed in the world. As the agricultural sector seeks innovative and efficient ways to enhance productivity and sustainability, the demand for DNA sequencing products is expected to increase further, driving advancements in agricultural activities and contributing to global food security, thereby positively impacting the DNA sequencing products market forecast.

DNA SEQUENCING PRODUCTS INDUSTRY SEGMENTATION :

Breakup by Product Type:

  • Consumables and Reagents
  • Equipments

Consumables and reagents dominate the market

According to the DNA sequencing products market overview, the consumables and reagents encompass various essential components and materials for conducting DNA sequencing experiments and analysis. Consumables include items like DNA extraction kits, sequencing libraries, and flow cells, while reagents consist of chemical substances and enzymes required during the sequencing process. The significance of this market segment lies in its vital role in facilitating DNA sequencing procedures, making it a crucial investment for researchers, clinicians, and other users. For instance, in April 2024, researchers at the Central India Institute of Medical Sciences - Advanced Research Centre (CIIMS-ARC) in Nagpur partnered with Caregenix, to develop a "Rapid DNA Extraction Kit."

Breakup by Application:

  • Biomarkers
  • Diagnostics
  • Reproductive Health
  • Forensics
  • Personalized Medicine
  • Others

Biomarkers dominate the market

Biomarkers are specific genetic, biochemical, or molecular characteristics that provide valuable insights into an individual's health status and treatment response. In the realm of DNA sequencing, biomarkers hold immense importance, especially in personalized medicine. Biomarkers derived from DNA sequencing data aid in predicting treatment outcomes, enabling healthcare professionals to tailor therapies based on a patient's genetic profile. This personalized approach enhances treatment efficacy and minimizes adverse effects, optimizing patient outcomes. According to the DNA sequencing products market outlook, the popularity of biomarkers in DNA sequencing products is driven by the increasing understanding of the link between genetics and disease, making them valuable tools in diagnostics, prognostics, and therapeutic decision-making. As the field of genomics continues to advance and more biomarkers are identified, the demand for DNA sequencing products, particularly those focused on biomarker analysis, is expected to grow significantly, further solidifying its prominent position in the market segment. For instance, in January 2024, Infinity Bio, Inc. launched its new antibody profiling platform, which uses Molecular Indexing of Proteins by Self-Assembly (MIPSA) technology. This platform provides depth in identifying new biomarkers and therapeutics. The MIPSA technology takes advantage of recent breakthroughs in high-throughput DNA sequencing and synthesis to generate and evaluate the most comprehensive immune target panels available.

Breakup by End-User:

  • Academic and Government Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Clinics
  • Others

Academic and government research institutes dominate the market

DNA sequencing products are currently experiencing significant utilization in academic and government research institutes. This trend can be attributed to the abundant research and development projects in these institutions that involve practical data analysis implementations and next-generation sequencing (NGS) . Academic and government research institutes are at the forefront of scientific exploration. DNA sequencing plays a crucial role in various areas of study, including genomics, molecular biology, agriculture, and healthcare research. The accessibility of advanced DNA sequencing technologies and the expertise of researchers in these institutions contribute to the widespread adoption of these products. Furthermore, academic and government research institutes often collaborate with DNA sequencing companies, fostering partnerships that promote innovation and enhance product development. As a result, the demand for these products remains robust in the academic and government sectors, driving the market growth and facilitating groundbreaking discoveries and advancements in scientific knowledge and applications.

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the DNA sequencing products largest market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. According to the report, North America accounted for the largest market.

According to the DNA sequencing products market statistics, the North American region is dominant in the global market. This can be attributed to several key factors driving the market growth in the region. The region has a substantial geriatric population, leading to an increased demand for genetic testing and personalized medicine to address age-related health concerns. Furthermore, the prevalence of various chronic diseases in North America has bolstered the adoption of DNA sequencing products for diagnostics, prognosis, and treatment decision-making. DNA sequencing is vital in identifying genetic factors contributing to these diseases, enabling targeted therapies and precision medicine approaches. Moreover, the region has several prominent drug manufacturers and biotechnology companies actively involved in genomic research and drug development. The presence of such industry players drives the demand for these products to support their research and clinical trials. For instance, in September 2022, Genome Prairie, in partnership with PRIESCAN, announced that it had officially delivered next-generation genome sequencing technology to Saskatchewan Polytechnic's BioScience Applied Research Centre (BARC) at its Saskatoon campus.

COMPETITIVE LANDSCAPE:

Top companies are bolstering market growth through several strategic approaches. They invest heavily in research and development to continuously improve their sequencing technologies, enhancing accuracy and scalability and reducing costs. This ensures that their products remain at the forefront of innovation and appeal to a broader customer base. Furthermore, these companies actively collaborate with academic institutions, research organizations, and healthcare providers to expand their customer reach and foster partnerships that drive product development and application. Additionally, they focus on expanding their product portfolios to cater to various customer needs, offering a range of DNA sequencing solutions tailored for different applications and industries. Moreover, effective marketing strategies, including targeted advertising, educational campaigns, and endorsements from key opinion leaders, create awareness and drive demand for their products. By employing these strategies and staying at the forefront of technological advancements, the top companies propel market growth and play a pivotal role in advancing genomics research, healthcare, agriculture, and other fields.

The report has provided a comprehensive analysis of the competitive landscape in the DNA sequencing products market. Detailed profiles of all major companies have also been provided.

  • Illumina Inc.
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd.
  • Pacific Biosciences of California, Inc.
  • Beckman Coulter

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global DNA sequencing products market in 2025?

2. What is the expected growth rate of the global DNA sequencing products market during 2026-2034?

3. What are the key factors driving the global DNA sequencing products market?

4. What has been the impact of COVID-19 on the global DNA sequencing products market?

5. What is the breakup of the global DNA sequencing products market based on the product type?

6. What is the breakup of the global DNA sequencing products market based on the application?

7. What is the breakup of the global DNA sequencing products market based on the end-user?

8. What are the key regions in the global DNA sequencing products market?

9. Who are the key players/companies in the global DNA sequencing products market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global DNA Sequencing Products Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product Type
  • 5.5 Market Breakup by Application
  • 5.6 Market Breakup by End-User
  • 5.7 Market Breakup by Technology
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast
  • 5.10 SWOT Analysis
    • 5.10.1 Overview
    • 5.10.2 Strengths
    • 5.10.3 Weaknesses
    • 5.10.4 Opportunities
    • 5.10.5 Threats
  • 5.11 Value Chain Analysis
    • 5.11.1 Research and Development
    • 5.11.2 Raw Material Procurement
    • 5.11.3 Manufacturing
    • 5.11.4 Distribution
    • 5.11.5 End-Use
  • 5.12 Porters Five Forces Analysis
    • 5.12.1 Overview
    • 5.12.2 Bargaining Power of Buyers
    • 5.12.3 Bargaining Power of Suppliers
    • 5.12.4 Degree of Competition
    • 5.12.5 Threat of New Entrants
    • 5.12.6 Threat of Substitutes

6 Market Breakup by Product Type

  • 6.1 Consumables and Reagents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Equipments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Biomarkers
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Reproductive Health
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Forensics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Personalized Medicine
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End-User

  • 8.1 Academic and Government Research Institutes
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmaceutical and Biotechnology Companies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hospitals and Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Europe
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Competitive Landscape

  • 10.1 Market Structure
  • 10.2 Market Breakup by Key Players
  • 10.3 Profiles of Key Players
    • 10.3.1 Illumina Inc
      • 10.3.1.1 Company Overview
      • 10.3.1.2 Description
      • 10.3.1.3 Product Portfolio
      • 10.3.1.4 Financials
      • 10.3.1.5 SWOT Analysis
    • 10.3.2 Thermo Fisher Scientific Inc.
      • 10.3.2.1 Company Overview
      • 10.3.2.2 Description
      • 10.3.2.3 Product Portfolio
      • 10.3.2.4 Financials
      • 10.3.2.5 SWOT Analysis
    • 10.3.3 F. Hoffmann-La Roche Ltd.
      • 10.3.3.1 Company Overview
      • 10.3.3.2 Description
      • 10.3.3.3 Product Portfolio
      • 10.3.3.4 Financials
      • 10.3.3.5 SWOT Analysis
    • 10.3.4 Pacific Biosciences of California, Inc.
      • 10.3.4.1 Company Overview
      • 10.3.4.2 Description
      • 10.3.4.3 Product Portfolio
      • 10.3.4.4 Financials
      • 10.3.4.5 SWOT Analysis
    • 10.3.5 Beckman Coulter
      • 10.3.5.1 Company Overview
      • 10.3.5.2 Description
      • 10.3.5.3 Product Portfolio
      • 10.3.5.4 Financials
      • 10.3.5.5 SWOT Analysis

List of Figures

  • Figure 1: Global: DNA Sequencing Products Market: Major Drivers and Challenges
  • Figure 2: Global: DNA Sequencing Products Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: DNA Sequencing Products Market: Breakup by Product Type (in %), 2025
  • Figure 4: Global: DNA Sequencing Products Market: Breakup by Application (in %), 2025
  • Figure 5: Global: DNA Sequencing Products Market: Breakup by End-User (in %), 2025
  • Figure 6: Global: DNA Sequencing Products Market: Breakup by Technology (in %), 2025
  • Figure 7: Global: DNA Sequencing Products Market: Breakup by Region (in %), 2025
  • Figure 8: Global: DNA Sequencing Products Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 9: Global: DNA Sequencing Products Industry: SWOT Analysis
  • Figure 10: Global: DNA Sequencing Products Industry: Value Chain Analysis
  • Figure 11: Global: DNA Sequencing Products Industry: Porter's Five Forces Analysis
  • Figure 12: Global: DNA Sequencing Products Market: Consumables and Reagents (in Million USD), 2020 & 2025
  • Figure 13: Global: DNA Sequencing Products Market Forecast: Consumables and Reagents (in Million USD), 2026-2034
  • Figure 14: Global: DNA Sequencing Products Market: Equipments (in Million USD), 2020 & 2025
  • Figure 15: Global: DNA Sequencing Products Market Forecast: Equipments (in Million USD), 2026-2034
  • Figure 16: Global: DNA Sequencing Products Market (Applications in Biomarkers): Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: DNA Sequencing Products Market Forecast (Applications in Biomarkers): Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: DNA Sequencing Products Market (Applications in Diagnostics): Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: DNA Sequencing Products Market Forecast (Applications in Diagnostics): Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: DNA Sequencing Products Market (Application in Reproductive Health): Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: DNA Sequencing Products Market Forecast (Applications in Reproductive Health): Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: DNA Sequencing Products Market (Applications in Forensics): Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: DNA Sequencing Products Market Forecast (Applications in Forensics): Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: DNA Sequencing Products Market (Applications in Personalized Medicine): Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: DNA Sequencing Products Market Forecast (Applications in Personalized Medicine): Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: DNA Sequencing Products Market (Other Applications): Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: DNA Sequencing Products Market Forecast (Other Applications): Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: DNA Sequencing Products Market (in Academic and Government Research Institutes): Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: DNA Sequencing Products Market Forecast (in Academic and Government Research Institutes): Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: DNA Sequencing Products Market (in Pharmaceutical and Biotechnology Companies): Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: DNA Sequencing Products Market Forecast (in Pharmaceutical and Biotechnology Companies): Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: DNA Sequencing Products Market (in Hospitals and Clinics): Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: DNA Sequencing Products Market Forecast (in Hospitals and Clinics): Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: DNA Sequencing Products Market (Other End-Users): Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: DNA Sequencing Products Market Forecast (Other End-Users): Sales Value (in Million USD), 2026-2034
  • Figure 36: North America: DNA Sequencing Products Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: North America: DNA Sequencing Products Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Europe: DNA Sequencing Products Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Europe: DNA Sequencing Products Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Asia Pacific: DNA Sequencing Products Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Asia Pacific: DNA Sequencing Products Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Latin America: DNA Sequencing Products Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Latin America: DNA Sequencing Products Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Middle East and Africa: DNA Sequencing Products Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Middle East and Africa: DNA Sequencing Products Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Global: DNA Sequencing Products Market: Breakup by Key Players (in %), 2025

List of Tables

  • Table 1: Global: DNA Sequencing Products Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: DNA Sequencing Products Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 3: Global: DNA Sequencing Products Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: DNA Sequencing Products Market Forecast: Breakup by End-User (in Million USD), 2026-2034
  • Table 5: Global: DNA Sequencing Products Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: DNA Sequencing Products Market: Competitive Structure
  • Table 7: Global: DNA Sequencing Products Market: Key Players